Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CanDiag Inc.

Blood test for detecting early-stage breast cancer

This article was originally published in Start Up

Executive Summary

CanDiag Inc. spun out of the University of North Carolina at Charlotte to develop an antibody-based blood test for detecting early-stage breast cancer. The start-up will first use the technology to develop a blood test for breast cancer recurrence, but the ultimate goal is to develop a test that can be used for women who have an abnormal mammogram; the test would be performed in lieu of additional expensive imaging studies and before performing biopsies.

Advertisement
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT037817

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel